Stocks to Watch today, December 15, 2025: Indian equities are set for a weaker start on Monday, tracking negative global cues ...
The 59-year-old Emmy-nominated showrunner joined his muse in a hot tub for an awkward Amanda Show segment, tried to get her ...
TipRanks on MSN
Novo Nordisk’s CagriSema study: A potential breakthrough for chronic kidney disease and diabetes
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk recently completed a study titled ‘Efficacy ...
The past 18 months have been absolutely terrible for Novo Nordisk (NYSE: NVO). The Denmark-based drugmaker has faced poor ...
Researchers adjusted for confounders like age, hypertension, cardiovascular disease, and other comorbidities. The refined results indicated GLP-1 users had a 16% lower risk of developing epilepsy ...
Welltica+ on MSN
GLP-1 drugs evaluated for potential impact on early Alzheimer’s
New findings from a major trial offer a clearer, more nuanced view of how GLP-1 medications may influence the course of ...
Global diabetes drug Ozempic (semaglutide) has now been launched in India by Danish pharmaceutical major Novo Nordisk. In an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback